Skip to main content
. 2021 Aug 26;22(10):1416–1426. doi: 10.1016/S1470-2045(21)00454-X

Table 2.

Patient outcomes by World Bank income group

Overall (n=1319) Low-income or lower-middle-income country (n=296) Upper-middle-income country (n=709) High-income country (n=314)
Disease severity
Asymptomatic 456/1301 (35·0%) 87/288 (30·2%) 233/702 (33·2%) 136/311 (43·7%)
Mild or moderate 586/1301 (45·0%) 81/288 (28·1%) 353/702 (50·3%) 152/311 (48·9%)
Severe or critical 259/1301 (19·9%) 120/288 (41·7%) 116/702 (16·5%) 23/311 (7·4%)
Treatment modification*
Treatment modified 609/1092 (55·8%) 163/240 (67·9%) 299/622 (48·1%) 147/230 (63·9%)
Chemotherapy reduced 80/609 (13·1%) 34/163 (20·9%) 41/299 (13·7%) 5/147 (3·4%)
Chemotherapy withheld 487/609 (80·0%) 125/163 (76·7%) 234/299 (78·3%) 128/147 (87·1%)
Radiotherapy delayed 25/609 (4·1%) 3/163 (1·8%) 14/299 (4·7%) 8/147 (5·4%)
Surgery delayed 41/609 (6·7%) 10/163 (6·1%) 20/299 (6·7%) 11/147 (7·5%)
Treatment on plan (includes unknown) 483/1092 (44·2%) 77/240 (32·1%) 323/622 (51·9%) 83/230 (36·1%)
Death
Due to COVID-19 50/83 (60·2%) 20/33 (60·6%) 26/43 (60·5%) 4/7 (57·1%)
Median time to death, days 8 (3–14) 9 (4–13) 7 (3–13) 20 (11–25)
Due to other causes 33/83 (39·8%) 13/33 (39·4%) 17/43 (39·5%) 3/7 (42·9%)
Median time to death, days 16 (8–29) 16 (8–29) 10 (4–21) 26 (24–32)
Hospitalisation
Hospitalised, ward status 658 (49·9%) 61 (20·6%) 472 (66·6%) 125 (39·8%)
Hospitalised, higher level of care 231 (17·5%) 117 (39·5%) 95 (13·4%) 19 (6·1%)
Not hospitalised 430 (32·6%) 118 (39·9%) 142 (20·0%) 170 (54·1%)

Data are n, n/N (%), n (%), or median (IQR).

*

Treatment modification corresponds to a “select all that apply” question in the survey, thus sum of count numbers could exceed total number.

Higher level of care included intensive care unit, intermediate care unit, high dependency unit, and emergency room.